MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617091048 A) filed by Fortvita Biologics Singapore Pte. Ltd. on July 27, 2026, for Pd-1/Il-2r Bispecific Antibody Fusion Protein, And Use And Usage Method Thereof.
Inventors include Zhou, Hui; Ding, Luyin; Chen, Yuling; He, Kaijie; Sun, Xing; and Zheng, Shirui.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention relates to a PD-1/IL-2R bispecific antibody fusion protein for treating tumors (such as solid tumors or hematologic tumors), or a pharmaceutical composition or pharmaceutical combination containing same, and a use and usage method thereof.
Disclaimer: Curated by HT Sy...